Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Other Non-Current Liabilities (2017 - 2025)

Historic Other Non-Current Liabilities for Cartesian Therapeutics (RNAC) over the last 10 years, with Q3 2025 value amounting to $848000.0.

  • Cartesian Therapeutics' Other Non-Current Liabilities fell 7638.54% to $848000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $848000.0, marking a year-over-year decrease of 7638.54%. This contributed to the annual value of $3.8 million for FY2024, which is 4000.63% down from last year.
  • As of Q3 2025, Cartesian Therapeutics' Other Non-Current Liabilities stood at $848000.0, which was down 7638.54% from $1.4 million recorded in Q2 2025.
  • Over the past 5 years, Cartesian Therapeutics' Other Non-Current Liabilities peaked at $45.5 million during Q1 2021, and registered a low of $848000.0 during Q3 2025.
  • Over the past 5 years, Cartesian Therapeutics' median Other Non-Current Liabilities value was $13.1 million (recorded in 2023), while the average stood at $17.0 million.
  • Per our database at Business Quant, Cartesian Therapeutics' Other Non-Current Liabilities soared by 23611.75% in 2023 and then plummeted by 8527.0% in 2025.
  • Over the past 5 years, Cartesian Therapeutics' Other Non-Current Liabilities (Quarter) stood at $25.4 million in 2021, then dropped by 24.71% to $19.1 million in 2022, then tumbled by 66.59% to $6.4 million in 2023, then crashed by 40.01% to $3.8 million in 2024, then plummeted by 77.89% to $848000.0 in 2025.
  • Its Other Non-Current Liabilities stands at $848000.0 for Q3 2025, versus $1.4 million for Q2 2025 and $2.0 million for Q1 2025.